| 301 |
272: Activation/Proliferation, T-cells |
312: N/A, Allergic contact dermatitis on challenge |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 835 |
272: Activation/Proliferation, T-cells |
827: sensitisation, skin |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1701 |
272: Activation/Proliferation, T-cells |
313: Increase, Allergic Respiratory Hypersensitivity Response |
Dec 7, 2017 |
Aug 1, 2022 |
1 AOP
|
| 3332 |
272: Activation/Proliferation, T-cells |
2256: Activation of gluten- and TG2-reactive B cells |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3334 |
272: Activation/Proliferation, T-cells |
1931: Disruption of the intestinal barrier |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3337 |
272: Activation/Proliferation, T-cells |
2252: Formation of HLA-DQ2/8-gluten complexes |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 2157 |
1793: AP-1 activation |
1795: TGFbeta expression |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 2523 |
1937: ADAM17 induction |
1938: ACE2 increased shedding |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2696 |
2025: Affected folate transporter |
2026: decrease folate |
Jul 19, 2022 |
Jul 19, 2022 |
1 AOP
|
| 31 |
25: Agonism, Androgen receptor |
129: Reduction, Gonadotropins, circulating concentrations |
Nov 29, 2016 |
Mar 20, 2017 |
1 AOP
|
| 32 |
25: Agonism, Androgen receptor |
274: Reduction, Testosterone synthesis by ovarian theca cells |
Nov 29, 2016 |
Mar 20, 2017 |
1 AOP
|
| 1384 |
25: Agonism, Androgen receptor |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Mar 17, 2017 |
Mar 20, 2017 |
1 AOP
|
| 1385 |
25: Agonism, Androgen receptor |
285: Reduction, Vitellogenin synthesis in liver |
Mar 17, 2017 |
Mar 20, 2017 |
1 AOP
|
| 2260 |
25: Agonism, Androgen receptor |
1790: Increased, Differentiation to Testis |
Jan 12, 2021 |
Jan 3, 2023 |
1 AOP
|
| 2349 |
25: Agonism, Androgen receptor |
1791: Increased, Male Biased Sex Ratio |
Apr 12, 2021 |
Jan 3, 2023 |
1 AOP
|
| 2926 |
25: Agonism, Androgen receptor |
2139: Reduction, the ratio of E2/11-KT in plasma |
May 22, 2023 |
May 22, 2023 |
None
|
| 3378 |
25: Agonism, Androgen receptor |
2274: Androgen receptor activation, increased |
Nov 2, 2024 |
Nov 24, 2024 |
1 AOP
|
| 3392 |
25: Agonism, Androgen receptor |
286: Altered, Transcription of genes by the AR |
Nov 16, 2024 |
Nov 16, 2024 |
2 AOPs
|
| 3450 |
25: Agonism, Androgen receptor |
716: Increase, cell proliferation (hepatocytes) |
Dec 23, 2024 |
Dec 23, 2024 |
1 AOP
|
| 3462 |
25: Agonism, Androgen receptor |
1599: Inflammatory events |
Dec 31, 2024 |
Dec 31, 2024 |
1 AOP
|
| 3463 |
25: Agonism, Androgen receptor |
1183: Decreased, Apoptosis (Epithelial Cells) |
Dec 31, 2024 |
Dec 31, 2024 |
1 AOP
|
| 126 |
111: Agonism, Estrogen receptor |
363: Altered, Reproductive behaviour |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 127 |
111: Agonism, Estrogen receptor |
364: Impaired development of, Reproductive organs |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 128 |
111: Agonism, Estrogen receptor |
307: Increase, Vitellogenin synthesis in liver |
Nov 29, 2016 |
Jun 24, 2024 |
3 AOPs
|
| 3525 |
111: Agonism, Estrogen receptor |
749: Decreased, Progesterone from corpus luteum |
Apr 17, 2025 |
Apr 17, 2025 |
1 AOP
|